BindingDB logo
myBDB logout

null

SMILES: Cc1[nH]c2ccc(Cl)cc2c1C1CCN(CC1)C1Cc2cccc3cccc1c23

InChI Key: InChIKey=OGLIFFKVFKYPEO-UHFFFAOYSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 50185796   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Nociceptin receptor


(Homo sapiens (Human))
BDBM50185796
PNG
(5-chloro-3-(1-(1,2-dihydroacenaphthylen-1-yl)piper...)
Show SMILES Cc1[nH]c2ccc(Cl)cc2c1C1CCN(CC1)C1Cc2cccc3cccc1c23
Show InChI InChI=1S/C26H25ClN2/c1-16-25(22-15-20(27)8-9-23(22)28-16)18-10-12-29(13-11-18)24-14-19-6-2-4-17-5-3-7-21(24)26(17)19/h2-9,15,18,24,28H,10-14H2,1H3
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
10n/an/an/an/an/an/an/an/a



Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL


Assay Description
Agonist activity at ORL1 receptor expressed in HEK293 cells by calciun flux assay


Bioorg Med Chem Lett 16: 3524-8 (2006)


Article DOI: 10.1016/j.bmcl.2006.03.094
BindingDB Entry DOI: 10.7270/Q2VT1RQJ
More data for this
Ligand-Target Pair
Mu-type opioid receptor


(Homo sapiens (Human))
BDBM50185796
PNG
(5-chloro-3-(1-(1,2-dihydroacenaphthylen-1-yl)piper...)
Show SMILES Cc1[nH]c2ccc(Cl)cc2c1C1CCN(CC1)C1Cc2cccc3cccc1c23
Show InChI InChI=1S/C26H25ClN2/c1-16-25(22-15-20(27)8-9-23(22)28-16)18-10-12-29(13-11-18)24-14-19-6-2-4-17-5-3-7-21(24)26(17)19/h2-9,15,18,24,28H,10-14H2,1H3
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
260n/an/an/an/an/an/an/an/a



Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL


Assay Description
Displacement of [3H]DAMGO from mu opioid receptor expressed in HEK293 cells


Bioorg Med Chem Lett 16: 3524-8 (2006)


Article DOI: 10.1016/j.bmcl.2006.03.094
BindingDB Entry DOI: 10.7270/Q2VT1RQJ
More data for this
Ligand-Target Pair
Kappa-type opioid receptor


(Homo sapiens (Human))
BDBM50185796
PNG
(5-chloro-3-(1-(1,2-dihydroacenaphthylen-1-yl)piper...)
Show SMILES Cc1[nH]c2ccc(Cl)cc2c1C1CCN(CC1)C1Cc2cccc3cccc1c23
Show InChI InChI=1S/C26H25ClN2/c1-16-25(22-15-20(27)8-9-23(22)28-16)18-10-12-29(13-11-18)24-14-19-6-2-4-17-5-3-7-21(24)26(17)19/h2-9,15,18,24,28H,10-14H2,1H3
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
680n/an/an/an/an/an/an/an/a



Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL


Assay Description
Displacement of [3H]U-69593 from kappa opioid receptor expressed in HEK293 cells


Bioorg Med Chem Lett 16: 3524-8 (2006)


Article DOI: 10.1016/j.bmcl.2006.03.094
BindingDB Entry DOI: 10.7270/Q2VT1RQJ
More data for this
Ligand-Target Pair
Delta-type opioid receptor


(Homo sapiens (Human))
BDBM50185796
PNG
(5-chloro-3-(1-(1,2-dihydroacenaphthylen-1-yl)piper...)
Show SMILES Cc1[nH]c2ccc(Cl)cc2c1C1CCN(CC1)C1Cc2cccc3cccc1c23
Show InChI InChI=1S/C26H25ClN2/c1-16-25(22-15-20(27)8-9-23(22)28-16)18-10-12-29(13-11-18)24-14-19-6-2-4-17-5-3-7-21(24)26(17)19/h2-9,15,18,24,28H,10-14H2,1H3
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
2.75E+3n/an/an/an/an/an/an/an/a



Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL


Assay Description
Displacement of [3H]DDPDE from delta opioid receptor expressed in HEK293 cells


Bioorg Med Chem Lett 16: 3524-8 (2006)


Article DOI: 10.1016/j.bmcl.2006.03.094
BindingDB Entry DOI: 10.7270/Q2VT1RQJ
More data for this
Ligand-Target Pair
Nociceptin receptor


(Homo sapiens (Human))
BDBM50185796
PNG
(5-chloro-3-(1-(1,2-dihydroacenaphthylen-1-yl)piper...)
Show SMILES Cc1[nH]c2ccc(Cl)cc2c1C1CCN(CC1)C1Cc2cccc3cccc1c23
Show InChI InChI=1S/C26H25ClN2/c1-16-25(22-15-20(27)8-9-23(22)28-16)18-10-12-29(13-11-18)24-14-19-6-2-4-17-5-3-7-21(24)26(17)19/h2-9,15,18,24,28H,10-14H2,1H3
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 5.46E+4n/an/an/an/a



Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL


Assay Description
Agonist activity at ORL1 receptor expressed in HEK293 cells by calciun flux assay


Bioorg Med Chem Lett 16: 3524-8 (2006)


Article DOI: 10.1016/j.bmcl.2006.03.094
BindingDB Entry DOI: 10.7270/Q2VT1RQJ
More data for this
Ligand-Target Pair